1,000
Participants
Start Date
December 31, 2010
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Research Site, Chelyabinsk
Research Site, Irkutsk
Research Site, Krasnodar
Research Site, Krasnoyarsk
Research Site, Moscow
Research Site, N.Novgorod
Research Site, Novosibirsk
Research Site, Perm
Research Site, Rostov-on-Don
Research Site, Saint Petersburg
Research Site, Ufa
Research Site, Yekaterinburg
Lead Sponsor
AstraZeneca
INDUSTRY